$0.13
2.55% today
Nasdaq, Apr 04, 03:50 pm CET
ISIN
BSP733981026
Symbol
NYMXF
Reports
Quarter | Annual
Index
NASDAQ Composite
Sector
Health
Industry
Medical specialties

Nymox Pharmaceutical Corp Stock News

Neutral
GlobeNewsWire
●
24 days ago
Nymox Announces Dismissal of Delaware Action Against Ascella
IRVINE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Nymox announces that it dismissed the Delaware matter pending against Ascella on March 7, 2025. A number of factors caused the company to reconsider its strategy to adequately protect its shareholders.

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now
The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today